ENORLA Trademark

Trademark Overview

On Wednesday, August 9, 2017, a trademark application was filed for ENORLA with the United States Patent and Trademark Office. The USPTO has given the ENORLA trademark a serial number of 87562410. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 15, 2024. This trademark is owned by Glaxo Group Limited. The ENORLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral and immune system related diseases and disorders
enorla

General Information

Serial Number87562410
Word MarkENORLA
Filing DateWednesday, August 9, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 15, 2024
Registration Number5457606
Registration DateTuesday, May 1, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral and immune system related diseases and disorders
Translation of Words in MarkThe wording "ENORLA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Saturday, August 12, 2017NEW APPLICATION ENTERED
Thursday, November 2, 2017ASSIGNED TO EXAMINER
Friday, November 10, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, November 17, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, November 17, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 17, 2017SUSPENSION LETTER WRITTEN
Friday, November 17, 2017LETTER OF SUSPENSION E-MAILED
Tuesday, December 5, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, December 7, 2017EXAMINER'S AMENDMENT ENTERED
Friday, December 29, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, December 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 7, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, December 7, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, December 7, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 26, 2017ASSIGNED TO LIE
Wednesday, January 10, 2018ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 1, 2018REGISTERED-PRINCIPAL REGISTER
Monday, May 7, 2018ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 1, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 15, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

enorla pharmaceutical treatment diseases substances preparations related disorders system viral infectious